Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit T Priest

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Bioorganic & Medicinal Chemistry Letters|April 23, 2017
Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophoresShuzhi Dong, Kelsey VanGelder, Zhi-Cai Shi, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart FailureHaifeng Tang, Yuping Zhu, Nardos Teumelsan, et al.
Biochemistry|July 28, 2004
A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain modelBirgit T Priest, Maria L Garcia, Richard E Middleton, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2016
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffoldYuping Zhu, Reynalda K de Jesus, Haifeng Tang, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical EvaluationShawn P Walsh, Aurash Shahripour, Haifeng Tang, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Bioorganic & Medicinal Chemistry Letters|April 23, 2017
Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophoresShuzhi Dong, Kelsey VanGelder, Zhi-Cai Shi, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart FailureHaifeng Tang, Yuping Zhu, Nardos Teumelsan, et al.
Biochemistry|July 28, 2004
A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain modelBirgit T Priest, Maria L Garcia, Richard E Middleton, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2016
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffoldYuping Zhu, Reynalda K de Jesus, Haifeng Tang, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical EvaluationShawn P Walsh, Aurash Shahripour, Haifeng Tang, et al.
Pageof 6